| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K66453893 |
| PharmacoGx | BRD-K66453893 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ORC2 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.003 |
| mRNA | KCNJ16 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.003 |
| mRNA | AFAP1L1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | PIF1 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.003 |
| mRNA | CEP120 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.003 |
| mRNA | DACH1 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.003 |
| mRNA | CDC42SE1 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.003 |
| mRNA | SNTA1 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.003 |
| mRNA | RLBP1 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.003 |
| mRNA | USP17L29 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.003 |
